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Background: Glucocorticoids (GCs) are natural stress induced steroid hormones causing cell cycle arrest and cell
death in lymphoid tissues. Therefore they are the central component in the treatment of lymphoid malignancies, in
particular childhood acute lymphoblastic leukemia (chALL). GCs act mainly via regulating gene transcription, which
has been intensively studied by us and others. GC control of mRNA translation has also been reported but has
never been assessed systematically. In this study we investigate the effect of GCs on mRNA translation on a
genome-wide scale.
Results: Childhood T- (CCRF-CEM) and precursor B-ALL (NALM6) cells were exposed to GCs and subjected to
“translational profiling”, a technique combining sucrose-gradient fractionation followed by Affymetrix Exon
microarray analysis of mRNA from different fractions, to assess the translational efficiency of the expressed genes.
Analysis of GC regulation in ribosome-bound fractions versus transcriptional regulation revealed no significant
differences, i.e., GC did not entail a significant shift between ribosomal bound and unbound mRNAs.
Conclusions: In the present study we analyzed for the first time possible effects of GC on the translational
efficiency of expressed genes in two chALL model systems employing whole genome polysome profiling. Our
results did not reveal significant differences in translational efficiency of expressed genes thereby arguing against a
potential widespread regulatory effect of GCs on translation at least in the investigated in vitro systems.
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Glucocorticoids (GCs) are natural stress-induced steroid
hormones, synthesized and secreted by the adrenal cortex.
GC plays an important role in the regulation of glucose
metabolism and is part of the anti-inflammatory feedback
mechanisms of the immune system. In addition to many
other immunological and metabolic effects, GC causes cell
cycle arrest and cell death in lymphoid cells, an effect that
led to the use of GC in essentially all chemotherapy proto-
cols for lymphoid malignancies, particularly childhood
acute lymphoblastic leukemia (chALL) [1]. Unfortunately,
GC therapy is not equally effective in all patients. The* Correspondence: johannes.rainer@i-med.ac.at
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reproduction in any medium, provided the ordegree of the early response to GC treatment is a deter-
minant of the intensity of subsequent therapy, and is also
a prognostic factor of the overall outcome. Therefore, fur-
ther investigation of molecular mechanisms responsible
for GC-induced apoptosis is required to better understand
the phenomenon of GC resistance.
It is generally believed that GC exerts most of its effects
through the GC receptor (GR, NR3C1), a ligand-activated
transcription factor of the nuclear hormone receptor
superfamily. In the absence of ligand, GR resides in the
cytoplasm in an inactive multi-protein complex consisting
of two hsp90 molecules and a number of other proteins,
including the immunophilins p59 and calreticulin [2]. Upon
ligand binding, the GR undergoes a conformational change
that causes dissociation of the multi-protein complex. GRs
can then form a dimer that translocates into the nucleus,al Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ally by binding specific DNA sequences known as gluco-
corticoid response elements (GRE). GRs can also remain
monomers and repress the activity of some transcription
factors [3].
Microarray technology allows analysis of gene expression
on a genome-wide scale, and thus has been extensively used
to identify transcriptional response genes in vitro in cell line
systems [4-8] as well as in chALL patients, in vivo [9] and
ex vivo [10]. Lists of candidate genes have been generated,
some of which have been functionally investigated [11],
but the exact mechanisms of action of GCs remain to be
elucidated. In addition to the widely studied transcriptional
regulation, some studies suggested translational regulation
by GCs of selected genes [12-14], but this question has
never been addressed systematically.
“Translational profiling” is a technique that combines
polysome profiling using sucrose gradient fractionation
with microarray technology to estimate translational effi-
ciency on a genome-wide scale. This technique, although
not directly measuring translation per se, is widely accepted
to estimate the translational efficiency of mRNAs [15,16]
and has been shown to provide a useful estimate of protein
synthesis [17].
In this project, we performed a genome-wide investigation
of translational regulation by GC in chALL. Comparison
of GC regulations in ribosome-bound fractions against
gene regulations in the full data set (i.e., transcriptional
gene regulations) revealed no significant difference, thus
suggesting that GCs do not influence mRNA translation,
at least in the cell systems analyzed. In addition, our
data enables evaluation of the translational efficiency of
genes expressed in the investigated systems.Figure 1 Representative example of Agilent gel electrophoresis of RNA f
Fractions 1–6 (pool 1) encompass non-ribosome bound RNAs, as suggested by
potentially containing translationally-initiated mRNAs (pool 2). Fractions 9–20 (p
of both ribosomal subunits 18S and 28S.Results and discussion
To address the question of translational regulation by
GC, two different GC-sensitive cell lines, representing two
major sub-types of ALL, were investigated: the CCRF-CEM
cell line corresponding to the childhood T-ALL sub-type,
and the NALM6 line, corresponding to pre-B ALL. Three
independent experiments for each cell line were performed.
Cells were cultured for 6 hours in the presence or absence
of GC followed by classical sucrose gradient fractionation
[18-21]. Twenty one to 23 different fractions were assigned
to one of three pools based on the presence of different
ribosomal subunits, referred to as non-translated (pool 1),
intermediate (pool 2) and translated (pool 3) pools
(see Figure 1 and Additional file 1:Figure S9). While this
pooling of fractions from sucrose gradients precludes draw-
ing conclusions on the regulation of translation elongation
or termination, it allows analyzing translational regula-
tion at the step of translation initiation. The initiation
phase is in fact the rate-limiting step in the process of
protein synthesis and also the most common target in
translational regulation [20,22,23]. Samples were then
hybridized to Affymetrix Exon 1.0 microarrays for gene
expression profiling, resulting in total of 36 microarrays
(2 cell lines, 2 treatments, 3 pools, 3 replicates).
We pre-processed the microarrays using a modified
version of the GCRMA method [8], which resulted in
summarized expression values per transcript probe set.
These transcript probe sets were annotated to IDs, gene
names, transcript biotypes and other information according
to the Ensembl database version 67. A single “representa-
tive” transcript probe set was chosen for genes measured
by multiple transcript probe sets on the microarray. Our
selection prioritized the protein coding transcripts withractions obtained by sucrose gradient separation from NALM6 cells.
the complete absence of 28S RNA. Fractions 7–8 form an intermediate pool
ool 3) contain mRNAs bound to ribosomes, as evidenced by the presence
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throughout arrays (see Methods for detailed description).
There were a total of 41325 genes, as defined by the
Ensembl database, detectable on the microarrays, each
represented by a chosen transcript. For further analysis,
we restricted the data to presumably expressed genes
(expression level higher than 3 in at least one pool, with
expression values of the microarrays ranging from 0 to 16
in log2 scale). For CEM-C7H2, 13874 genes were consid-
ered to be expressed, and for NALM6, 16289 (see Table 1).
To estimate the translational efficiency of the transcripts,
we calculated the relative expression (RE) in each pool
using a measure representing the percentage of RNA in
each of the three pools for the respective gene. We will
refer to RE in pool 3 as translational efficiency of the gene
(see Methods) following the definition in [17]. We next se-
lected the top 1% of genes with the highest RE in different
pools and grouped them according to transcript biotypes,
a classification scheme defined in the Ensembl database
that groups genes or transcripts based on their function or
structure. There were 36 different biotypes, including
protein coding, pseudogene, lincRNA etc. The full list
of biotypes represented on the microarray, as well as
the number of genes of each biotype, are shown in
Table 1. Figure 2 shows the presence of different bio-
types among the top 1% of genes with the highest RE
in corresponding pools for the CEM-C7H2 cell line
treated with GC. We observed an enrichment of non-Table 1 Summary of the biotype assignment of genes
expressed in the two cell lines
C7H2 NALM6 Detectable*:
protein_coding 10318 11129 19229
processed_transcript 236 297 1010
sence_intronic 32 55 353
misc_RNA 156 217 784
snRNA 111 176 969
miRNA 42 56 196
snoRNA 205 264 745
rRNA 51 82 276
scRNA_pseudogene 213 232 620
Mt_tRNA_presudogene 31 44 277
Other biotypes 2479 3737 16866
Total number of genes: 13874 16289 41325
Summary of the biotype assignment of genes expressed in the two cell lines
and of all genes detectable on the microarray. Other biotypes include
pseudogene, lincRNA, antisense, polymorphic_pseudogene, non_coding,
IG_V_pseudogene, ncrna_host, IG_C_gene, IG_J_gene, IG_V_gene, TR_J_gene,
TR_V_gene, TR_V_pseudogene, TR_C_gene, TR_J_pseudogene,
IG_C_pseudogene, IG_D_gene, sense_overlapping, 3prime_overlapping_ncrna,
snoRNA_pseudogene, rRNA_pseudogene, tRNA_pseudogene,
snRNA_pseudogene, miRNA_pseudogene, misc_RNA_pseudogene. Total
number of genes annotated by Ensembl version 67: 51455. *) Detectable on
the microarray.coding biotypes among those with the highest RE in
pool 1, consistent with the assumption that this pool
contained non-translated RNA. Similarly, among genes
with the highest RE in pool 3, > 95% were protein coding.
Both cell lines and both treatments showed very similar
results (Additional file 1: Figure S1).
Our subsequent analysis focused on protein coding
genes, since the translation rate is only applicable to them.
There were 10318 genes investigated in CEM-C7H2, and
11129 in NAML6. Exploratory analysis of the data indi-
cated that the translational efficiency of protein coding
genes varies significantly. Distribution of RE in pool 3 for
protein coding genes is illustrated in Figure 3. The shape
of the distribution for translational efficiency is consistent
with results from other studies [15,17] including a study
using a different approach for assessing translational effi-
ciency, i.e., relation of mRNA to quantitative proteomics
data corrected for protein degradation [24]. Distribution
for the NALM6 cell line was narrower around the median,
while distribution for C7H2 is more widespread. Both cell
lines skew slightly positive, suggesting fewer genes with
very high translational efficiency. Distribution of RE for
GC-treated and EtOH-treated samples are nearly the same,
implying no global effect of GC on translational efficiency
of the genes. As indicated by distribution density function,
the majority of genes had their mRNA evenly distributed
throughout pools. Some genes had extremely high transla-
tional efficiencies, with up to 97% of their mRNA being in
pool 3. For example, TLN1 had an average translational
efficiency of 0.898 in both cell lines, indicating that as much
as 89.8% of its mRNA was located in pool 3 [95% confi-
dence interval for translational efficiency was (0.885, 0.911),
based on 3 experiments, both cell lines and both treat-
ments; Figure 4A]. On the other hand, some genes ap-
peared weakly translated, if at all. CCDC7, for example,
was identified as a poorly-translated protein coding
gene with translational efficiency as low as 0.011, indi-
cating that only 1.1% of its mRNA is associated with
ribosomes [95% confidence interval for translational
efficiency was (0.006, 0.015) based on 3 experiments,
both cell lines and both treatments; Figure 4B]. The
translational efficiencies between C7H2 and NALM6
cells were highly comparable for genes expressed in
both cell lines (Additional file 1: Figure S2). The average
relative expression and average expression of all genes in
the various pools is provided in Additional files 2 and 3
for C7H2 and NALM6 cells, respectively.
Having determined the translational efficiency for all
genes we were now able to address whether genes with
similar translational efficiency might also be functionally
related. We tested this similar to Stevens et al. [24] by
dividing all expressed protein coding genes into five
groups based on their translational efficiency. On each
subset we performed Gene Ontology (GO) analyses to
Figure 2 Distribution of biotypes for the genes with the highest relative expressions in the corresponding pool. Distribution of biotypes
in pools 1 (left panel) and 3 (middle panel) for the top 1% of genes with the highest relative expression in the corresponding pool compared to
the total number of genes on the microarray (right panel). Shown are the results for EtOH-treated C7H2 cells. For the complete list of biotypes of
the genes detectable on the microarray, see Table 1.
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(Additional file 1: Tables S3–S14). The 3 gene sets with
intermediate translational efficiency did not yield consistent
results between the 2 cell lines, i.e., enrichment in particular
processes was observed in one but not the other cell line.
In contrast, in both cell lines the same GO terms were
enriched in the gene set with the highest translational effi-
ciencies. Similar to [24], these included RNA processing
related terms (“mRNA splicing, via spliceosome”, “mRNA
metabolic process” etc; Additional file 1: Table S3). Genes
from the group with the lowest translational efficiencies
were also enriched in both cell lines and concerned the
GO terms “viral transcription” and translation related
processes (“translation termination”, “translation elongation”
and “translation initiation”; see Additional file 1: Table S4).
In agreement with the latter finding, the synthesis of many
mammalian proteins associated with the translation appar-
atus is regulated at the translational level [25] to allow for
fast responses to changes in physiological conditions. Even
in growing cells, the mRNA from about 30% of ribosomalFigure 3 Distributions of translational efficiencies of protein-coding g
genes expressed as proportions of the gene mRNA in pool 3 for CEM-C7H2
corresponds to GC- and EtOH-treated samples, respectively. Dotted lines inproteins, most of which harboring the terminal oligo-
pyrimidine tract (TOP) motif, has been described to be
sequestered in mRNP particles and thus not being
actively translated [25]. Furthermore, genes with TOP
motifs (taken from Davuluri et al. [26]) had on average
slightly lower translational efficiency than all genes
(0.29 versus 0.34 in C7H2 and 0.23 versus 0.35 NALM6
cells with p-values for significance of this difference being
0.002 and < 0.001, respectively). The GO results for both
cell lines and all groups are provided in Additional file 1:
Tables S5 to S14.
Next, we assessed whether microRNAs (miRNAs) might
be involved in determining the translational efficiency of
genes. miRNAs are major post-transcriptional regulators of
gene expression that are thought to bind to specific sites in
the 3′ UTR of the target gene’s mRNA and subsequently
repress protein synthesis by destabilizing mRNA and/or
inhibiting translation [27]. miRNA mediated inhibition of
translation initiation would lead to a decreased expression
of the gene’s mRNA in ribosome bound fractions comparedenes. Distributions of translational efficiencies of all protein-coding
(left panel) and NALM6 (right panel) cells. Red and blue color
dicate the median values.
Figure 4 Expression levels of mRNA for representative genes with high (A) and low (B) translational efficiencies. X-axis indicates 3 pools:
non-translated (pool 1), intermediate (pool 2) and ribosome-bound (pool 3). Y-axis represents the expression level in log2 scale. Each dot
corresponds to the average expression in 3 biological experiments, error bars show standard deviation. Values for GC- and EtOH-treated samples
are drawn in red and blue, respectively. CEM-C7H2 cell line is indicated by solid lines, and NALM6 by dashed lines.
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translational efficiency of the gene. To test for such repres-
sions we analyzed in each cell line the 3′ UTRs of the 5%
of genes with the lowest translational efficiency for a signifi-
cant over-representation of binding sites of certain miRNA
families. Note that detection of repression via mRNA
destabilization, which has been recently proposed to be
the major pathway for miRNA mediated repression [28],
would not be possible with the present translatome
data, since it would lead to decreased mRNA levels in
both ribosome bound and un-bound fractions. Among
the genes with lowest translational efficiencies we iden-
tified, among others, a significant enrichment of miR-
NAs known to be upregulated in lymphoid disorders
(see Additional file 1: Tables S15 and S16 for the full ta-
bles). Many of the poorly translated genes are predicted
targets of miRNAs from the miRNA clusters miR-17 ~ 92,
miR-106a ~ 363, miR-106b ~ 25 (namely miR-17, miR-19a,
miR-19b, miR-20a, miR-93, miR-106a and miR-106b) as
well as of miRNAs miR-30a, miR-30c, miR-30e, miR-181a,
miR-181b and miR-26a. All of these miRNAs are known
to be over-expressed in ALL cells or lymphoid malignan-
cies [29] and are also highly expressed in the C7H2 cells
used in the present study [6]. These results suggest that
some of the poorly translated genes in C7H2 and NALM6
cells might indeed be under the control of some highly
expressed microRNAs. More detailed information is
provided in the supplement.
Finally, and most importantly, to investigate a possible
effect of GC on translation, differential regulation analysis
was performed. We defined the translational regulation of a
gene as the difference between GC-regulation of ribosome-
bound mRNA in pool 3 and its transcriptional regulation
as defined by GC-regulation of the total mRNA regardless
of the pool (see Methods). Translational regulation was cal-
culated for each gene in each of the three experiments, and
moderated t-tests [30] were performed. Resulting p-valueswere adjusted for multiple hypothesis testing using the
method of Benjamini and Hochberg [31]. In CEM-C7H2,
the lowest adjusted p-value was 0.079, and in NALM6, all
adjusted p-values were close to 1, therefore none of the
genes had translational regulation significantly different
from 0 (at a false discovery rate of 5%). GC-treatment thus
does not affect the translational efficiency of expressed
genes in the two chALL model systems.
Summarizing, the RE scores for each gene provided as
supplemental data will enable other researchers to evaluate
the potential translational efficiency of any gene expressed
at the transcriptional level in the ALL system. When
analyzing groups of genes with similar translational effi-
ciency we found for both cell lines enrichments in common
biological functions for genes with very high or very low
translational efficiencies. Furthermore, in an analysis of pre-
dicted miRNA target sites in the 3′ UTR of poorly trans-
lated genes, we found also evidence for miRNA mediated
post-transcriptional gene repression. More importantly, our
genome-wide translational profiling showed that GCs do
not influence the translational efficiency of expressed genes
in the two childhood ALL model systems investigated.
Conclusions
It is well established that GC treatment leads to transcrip-
tional gene regulations, a fact that has been extensively
studied in various cell systems by us and others. Some
studies, however, reported an influence of GCs on the
translational efficiency of selected genes [12-14], most of
them analyzed using cell free translation systems [12,13].
Here we investigated for the first time the influence of GC
treatment on translational efficiency of expressed genes
on a genome-wide scale employing sucrose-gradient
fractionation based ribosome profiling in combination
with microarray analysis of mRNA from different fractions.
Comparison of GC regulation in ribosome-bound frac-
tions versus GC regulation in the full data set revealed
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directly regulate mRNA translation. This, although being
a negative result, represents a major finding of importance
to the field, since it essentially excludes a potential
widespread role of GCs in translational gene regula-
tion, at least in the investigated systems. Whether this
conclusion derived from in vitro systems extends to
the in vivo situations remains to be shown.
In addition, we provide a comprehensive data set with
translational efficiencies and average expression of all genes
detectable on Affymetrix Exon 1.0 microarrays in various
pooled fractions from the translatome experiments thus en-
abling other researchers to evaluate translational efficiencies
of their candidate genes in ALL cells.
Methods
Cell lines and cell culture
The preB-ALL cell line NALM6 (Acc. No. 128,
DSMZ-Deutsche Sammlung von Mikroorganismen und
Zellkulturen, Braunschweig, Germany) and the childhood
T-ALL line CCRF-CEM-C7H2 [32] were cultured in RPMI
1640 supplemented with 10% fetal calf serum and 2 mM
L-glutamine at 37°C, 5% carbon dioxide, and saturated
humidity. The cells were free of mycoplasma infection,
and their authenticity was verified by DNA fingerprinting
as detailed previously [9,33].
Sucrose gradient centrifugation and RNA preparation
Fifty to 100×106 CEM-C7H2 or NALM6 cells were in-
cubated with 10-7 M dexamethasone or 0.1% ethanol
(as carrier control) for 6 h, washed twice in PBS, resus-
pended in 1 ml ice cold lysis buffer (10 mM Tris–HCl,
pH8.0, 140 mM NaCl, 1.5 mM MgCl2, 0.5% Nonidet-P40,
2 mM dithiothreitol, 500U/ml RNAsin), centrifuged at
12.000 g for 10 sec at 4°C to remove the nuclei, and the
supernatant (supplemented with 20 mM dithiothreitol,
150 μg/ml cycloheximide, 665 μg/ml heparin, 1 mM
phenylmethylsulfonyl fluoride, 0.5% deoxycholate) was
layered onto 10 ml of al linear sucrose gradient (15-40%,
supplemented with 10 mM Tris–HCl, pH 7.5, 140 mM
NaCl, 1.5 mM MgCl2, 10 mM dithiothreitol, 100 μg/ml
cycloheximide, 0.5 mg/ml heparin). After 120 min centrifu-
gation at 240.000 g at 4°C, 500 μl fractions were collected.
SDS and EDTA was added to a final concentration of 1%
and 10 mM, respectively, and the mixture was digested
with 100 μg protein kinase K for 30 min at 37°C. There-
after, total RNA was prepared using the Trizol method,
quantiated by OD measuring at 230, 260 and 280 nm
and analyzed on an Agilent Bioanalyzer (Figure 1 and
Additional file 1: Figure S9). Based on the distribution
of 18S and 28S RNA, the individual RNAs were com-
bined in 3 pools, subjected to a DNase digest, purified
using RNeasy MiniElute Cleanup Kit and precipitated
in 2.5 M LiCl, resuspended in nuclease free water andanalyzed by OD measurements and Agilent Bioanalyzer as
described above.
Microarray analysis
Affymetrix Exon 1.0 microarrays for 30 of the 36 samples
were generated as described [8]. In brief, 1.5 μg of
cytoplasmic RNA extracted from the sucrose gradients
was depleted of rRNA and transcribed into cDNA using
T7-promoter-tagged hexamer primers according to the
manufacturer’s protocols and reagents. Antisense RNA
was produced by T7-polymerase and subsequently
transcribed into cDNA using random priming in the
presence of dUTP, used to enzymatically fragment the
cDNA. For the remaining 6 samples from one experiment
of the NALM6 cell line, Affymetrix Exon 1.0 microarrays
were generated using protocols and kits from Ambion
that employ specific hexamer primers that do not bind
to, and thus amplify, ribosomal RNA. The protocol was
similar to the one described above with the exception
of the unnecessary rRNA reduction step. The resulting
targets for all samples were hybridized to human Exon
1.0 ST arrays. After washing and staining in an Affymetrix
450S fluidics station, the microarrays were scanned in
an Affymetrix 3000 scanner and fluorescence signal
intensities were recorded. Raw and preprocessed data
have been deposited at the Gene Expression Omnibus
(accession number: GSE48680).
Probe alignment, custom annotation and pre-processing
For preprocessing of the microarrays, the R package
“generalgcrma”, described in [8] was used. Probe sequences
from the Exon microarray were aligned to the human
genomic sequence (Ensembl version 67; genome assembly
GRCh37) and annotated to the respective gene’s exon if
their alignment was inside exon boundaries. Probes with
multiple and partial alignments were excluded from the
analysis. Custom “CEL definition files”, required for the
analysis of the Affymetrix Exon 1.0 microarrays, were
compiled defining a probe set for each transcript. Back-
ground adjustment, normalization and summarization
of the microarray data was done using the GCRMA
method [34]. As part of the preprocessing procedure,
the data set was subset to a single “representative” tran-
script probe set per gene, as multi-transcript genes were
also measured by multiple transcript probe sets on the
microarray. In the selection of the representative probe
set, preference was given to protein coding transcripts,
transcripts with >3 probes and those with the highest
average expression throughout the arrays. The choice of
transcripts was performed separately for 2 cell lines, and
thus different transcripts could be chosen for the same
gene in different cell lines. All the further data manipu-
lations were performed separately on the two cell lines.
At the last step of preprocessing, the transcripts with
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in all three pools and both treatments were eliminated
from further analysis.
Relative expression
To evaluate the translational efficiency of the transcripts
chosen for a particular gene, a measure of relative expres-
sion in each pool was used. This measure represents the
percentage of RNA in each of three pools for the gene. As a
result of the pre-processing, gene expression is expressed in
log2 scale, thus RE is calculated as follows:
RE ¼ 2
Ei
2E1 þ 2E2 þ 2E3
where Ei represents log2 expression of a transcript in pool
i, i ∈ 1, 2, 3. RE in pool 3 is referred to as the translational
efficiency of the gene.
Analysis of differential regulation (translational regulation)
by GC
To test our hypothesis of translational regulation by GC,
pair-wise comparison of regulation by GC in pool 3 vs
transcriptional regulation by GC was performed. To assess
the significance of this differential regulation, a moder-
ated t-test, implemented in R-package “limma” [30],
was employed. The resulting p-values were adjusted
for multiple hypothesis testing using the method of
Benjamini-Hochberg [31]. Transcriptional regulation
was defined by averaging gene expression throughout
pools for each condition (GC- and ethanol-treated) using
the following formula:
Etotal ¼ log2
2E1 þ 2E2 þ 2E3
3
 
(where Ei represents log2 expression of a transcript in pool
i, i ∈ 1, 2, 3). Regulation of total mRNA level (referred to as
“transcriptional regulation”) was calculated as the difference
between total mRNA in GC- and EtOH-treated samples:
M ¼ EGCtotal−EEtOHtotal
Gene ontology analysis
For Gene Ontology analysis we used the GOstats [35]
package from Bioconductor. We employed a conditional
test to enrich for more specific GO terms. All protein co-
ding genes with an expression higher than 3 in at least
one pool and treatment were used as background gene set
for the hypergeometric testing, as suggested by [36].
Analysis of genes with TOP motif
The database of classified 5′ UTRs from Davuluri et al.
[26] has been downloaded from ftp://ftp.cshl.org/pub/
science/mzhanglab/ramana and the provided GenBankidentifiers have been mapped to NCBI Entrezgene IDs
using annotation facilities from Bioconductor (i.e. the
“org.Hs.eg.db” package). From the in total 2312 GenBank
identifiers, only 1329 could be annotated the Entrezgene
IDs, with 1312 being detectable on the microarray. Of
these, 83 harbor a TOP motif in their UTR, and are
thought to be poorly translated (class II in Davuluri et al.).
A one tailed Student’s t-test has been employed to test
whether genes with a TOP motif have on average a
lower translational efficiency compared to all genes.miRNA target gene analysis
miRNA target gene predictions were extracted from the
Targetscan database version 6.2 [37]. For the analysis, only
predicted (conserved) targets of conserved miRNA families
were considered. Similar to the GO analysis, a hypergeo-
metric test was used to test for over-representation of
miRNA target sites in the 3′ UTR of the 5% of genes with
the lowest translational efficiency. The background gene
set consisted of all protein coding genes with an expres-
sion higher than 3 in at least one pool that are potentially
targeted by at least one miRNA (6899 and 7192 genes for
C7H2 and NALM6 cells, respectively).Availability of supporting data
The data set supporting the results of this article is available
in the Gene Expression Omnibus (accession number:
GSE48680).Additional files
Additional file 1: Supplementary Figures and Tables.
Additional file 2: Average expression and relative expression in the
various pools of all genes detected on the Exon microarray in C7H2
cells. Columns "transcript_id", "gene_id", "probe_count", "gene_name",
"gene_biotype" and "chromosome_name" contain annotations for the
respective probe set id on the microarray. Columns "RE.p1", "RE.p2",
"RE.p3" contain averaged relative expression across the 3 biological
replicates of each gene in pools 1, 2 and 3 respectively. Columns "exprs.
p1", "exprs.p2" and "exprs.p3" contain averaged expression of a gene
across the 3 biological replicates (log2 scale). Suffix "GC" and "EtOH"
indicate the treatment.
Additional file 3: Average expression and relative expression in the
various pools of all genes detected on the Exon microarray in
NALM6 cells. For a description of the content, see Additional file 2.Competing interests
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